Lung Cancer

Safely treat high-risk lung tumors, delivering ablative doses with less toxicity to critical surrounding structures.

With more than 2 million cases diagnosed each year, lung cancer is the most common type of cancer.1 And, with more than 1.7 million lung-cancer related deaths annually, also the deadliest.1 The high rate of mortality is attributed to two key factors: it is difficult to diagnose in early stages and is difficult to treat.2 Significant challenges include the location of the tumor, motion, and pulmonary comorbidity.3

But today, MRIdian is changing the paradigm for high-risk lung cancer.

  • MRIdian’s real-time tumor tracking and automatic beam gating make it possible for clinicians to treat lung tumors – even central and ultra-central lung tumors – with ablative doses of radiation while reducing toxicity to surrounding healthy tissue and sparing organs at risk.3-8
  • Ablative doses have been shown to drive favorable treatment outcomes.3-5
  • MRIdian may allow clinicians to treat patients with fewer doses – in some cases, a single radiation treatment.3,4,9

Scroll down to learn more about MRIdian treatment for lung cancer.


1Ferlay, J., et al. (2018). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Retrieved August 30, 2019 from
2Ciupki, B., 2020. Why Is Lung Cancer So Deadly? – National Foundation for Cancer Research. [online] NFCR. Available at: [Accessed 10 November 2020].
3Finazzi T, Haasbeek CJA, Spoelstra FOB, Palacios MA, Admiraal MA, Bruynzeel AME, Slotman BJ, Lagerwaard FJ, Senan S. (2020) Clinical outcomes of stereotactic MR-guided adaptive radiation therapy for high-risk lung tumors. International Journal of Radiation Oncology • Biology • Physics (2020); 107(2),270-278.
4Finazzi, T., Palacios, M. A., Haasbeek, C. J. A., Admiraal, M. A., Spoelstra, F. O. B., Bruynzeel, A. M. E., et al. Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors. Radiotherapy and Oncology. 144 (2020) 46-52.
5Schneider BJ, Daly ME, Kennedy EB, et al. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. J Clin Oncol. 2018;36(7):710–719.
6Henke, L. E., Olsen, J. R., Contreras, J. A., Curcuru, A., DeWees, T. A., Green, O. L., et al. (2018). Stereotactic MR-guided online adaptive radiation therapy (SMART) for ultracentral thorax malignancies: results of a phase 1 trial. Advances in Radiation Oncology. 4(1), 201–209.
7Song, S. Y., Choi, W., Shin, S. S., Lee, S. W., Ahn, S. D., Kim, J. H., et al. (2009). Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Lung Cancer. 66(1), 89–93.
8Finazzi, T., Palacios, M. A., Spoelstra, F. O. B., Haasbeek, C. J. A., Bruynzeel, A. M. E., Slotman, B. J., et al. (2019). Role of on-table plan adaptation in MR-guided ablative radiation therapy for central lung tumors. International Journal of Radiation Oncology • Biology • Physics, 104(4), 933–941.
9Finazzi T, van Soerensen de Koste J, Palacios M, Spoelstra F, Slotman BJ, Haasbeek C, et al. (2020) Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy. Phys Imag Radiat Oncol;14:17–23.

Important Safety Information

Indications for Use (IFU): The MRIdian Linac system, with magnetic resonance imaging capabilities, is intended to provide stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated. The MRIdian Linac System is not appropriate for all patients, including those who are not candidates for magnetic resonance imaging.

Important Safety Information (ISI): Radiation treatments may cause side effects that can vary depending on the part of the body being treated. The most frequent ones are typically temporary and may include, but are not limited to, irritation to the respiratory, digestive, urinary or reproductive systems; fatigue; nausea; skin irritation; and hair loss. In some patients, side effects can be severe. Treatment sessions may vary in complexity and duration.

Radiation treatment is not appropriate for all cancers. You should discuss the potential for side effects and their severity as well as the benefits of radiation and magnetic resonance imaging with your doctor to make sure radiation treatment is right for you.

Disclaimer: The opinions and clinical experiences presented herein are specific to the featured physicians and the featured patients and are for information purposes only. Nothing in this material is intended to provide specific medical advice or to take the place of written law or regulations. Results of treatment presented in the videos and information on this webpage are not indicative of typical or future results.

Discuss treatment options with your doctor, including the risks and benefits of the entire course of treatment specific to your individual needs. MRIdian Linac systems are only available at appropriately equipped facilities with specially trained physicians.

WEBINAR: "One and Done" Single Fraction: The Future of MR-Guided Lung Radiotherapy?

Watch Now: MRIdian for Lung Cancer at Amsterdam UMC

Safely treating lung tumors with ablative doses can be challenging, from central and ultra central to single fraction requires a new level of precision and accuracy. See how Amsterdam University Medical Center is using MRIdian to treat smarter with ablative doses that work harder to destroy tumors and spare healthy tissues. Join this webinar where they will share their experience treating lung cancer with single fraction SABR. With the potential to improve outcomes, reduce side effects and deliver better patient quality of life, is this the future of cancer care? Come see what you may be missing.


Prof. Suresh Senan, MDProfessor of Clinical Experimental Radiotherapy

Miguel Palacios, PhD, Medical Physicist 

Related Documents

MRIdian Key Scientific Study Summary
MRIdian Key Scientific Study Summary
Lung Bibliography

MRIdian In The News Related To Lung Cancer

Treating cancer with MRI-guided radiation therapy

The NewYork-Presbyterian Hospital and Weill Cornell Medicine - New York, NY - 2:09 minutes

MDs: Himanshu Nagar, MD and Nicholas Sanfilippo, MD

Producer: Fox5 News

Lung tumor, 5 days of radiation therapy

  • Accurately hit a tumor with radiation, even with subtle patient movements (breathing, hiccups)
  • Radiation is automatically turned off until tumor returns to exact position
  • Protect healthy surrounding tissues from radiation

December 20, 2018

First in world: MRI-Guided radiation therapy with MRIdian Linac

Henry Ford Cancer Institute - Cottage - Detroit, MI - 1:51 minutes

MDs: Benjamin Movsas, MD

Producer: Henry Ford TV

  • Offers radiation oncologists the ability to see the exact location of the tumor in real-time using MRI
  • Better radiation treatments will improve patients lives
  • ViewRay technology fits with the focus on precision medicine; better targeting, precision radiation

July 16, 2019

ViewRay program at UCLA offers groundbreaking treatment for cancer patients

UCLA Health, Jonsson Comprehensive Cancer Center - Los Angeles, CA - 3:15 minutes

MDs: Percy Lee, MD; Nzhde Agazaryan, PhD, DABR

Producer: UCLA Health

Lung cancer

  • “Adaptive radiotherapy”- patient therapy can be customized on a daily basis
  • Better outcomes and reduction of side effects
  • Increasing efficacy of radiation in getting rid of tumors

May 10, 2016

ViewRay Opens Window to See Cancerous Tumors in Real Time | UCLA Vital Signs

UCLA Health, Jonsson Comprehensive Cancer Center - Los Angeles, CA - 2:53 minutes

MDs: Percy Lee, MD; Minsong Cao, PhD

Producer: UCLA Health

  • Department is proud to acquire most advanced technology to benefit patients (2015)
  • For the first time, we can visualize the tumor while radiation treatment is going on
  • Usually rely on CT scan and fiducials but organs move and cannot adjust for movement in real-time, you can with ViewRay
  • “Gated” treatment: radiation will only occur when tumor is exactly at radiation target site
  • Amazed by quality of images which will change the way we deliver radiation: personalized for patients needs

January 9, 2015

News Articles Related To Lung Cancer

Scientific Presentations Related To Lung Cancer

MRIdian SMART for Lung Cancer; Dr. Stephen Rosenberg, Moffitt Cancer Center

MR Guided Central and Ultra-Central Lung SBRT: Lung SBRT Introduction and Workflow

Dr. Rupesh Kotecha, MCI & Dr. Stephen Rosenberg, Moffitt Cancer Center

Advantages of Low Field Strength for RT

John Bayouth, PhD
Carbone Cancer Center, University of Wisconsin – Madison
AAPM 2019

Dr. Bayouth has been compensated by ViewRay for his services in preparing and presenting this material for ViewRay’s further use and distribution.

The Emerging Role of Online Adaptive Radiotherapy in the Treatment of Lung Cancer

Lauren Henke, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
ASTRO 2018

Dr. Henke has been compensated by ViewRay for her services in preparing and presenting this material for ViewRay’s further use and distribution.

3 Years of Experience with MR-IGRT at Washington University

Vivian Rodriguez, Ph.D.
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine – St. Louis, MO
AAPM 2017

Dr. Rodriguez has been compensated by ViewRay for her services in preparing and presenting this material for ViewRay’s further use and distribution.

Low field MRI on Viewray MRIdian

Yingli Yang, Ph.D.
UCLA Health, Jonsson Comprehensive Cancer Center – Los Angeles, CA
AAPM 2017

Dr. Yang has been compensated by ViewRay for her services in preparing and presenting this material for ViewRay’s further use and distribution.

Videos Related To Lung Cancer

RayZR Double Focused MLC

Image and treat simultaneously with MRIdian® because organ motion matters!

June 13, 2018

MRIdian Linac Technology Overview

Introducing MRIdian® the world’s first MRI-guided radiation therapy system that can image and treat cancer patients simultaneously.

June 13, 2018

  Global Info


Please log in to access the ViewRay Customer Portal. To request access, please click here. Request will be reviewed within 2 business days.

Existing Users Log In

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy